tirzepatide and iih Tirzepatide: A First-in-class Twincretin for the Management of Type 2 Diabetes Management of IIH. The treatment

Thanks to modern technology, more accurate information is publicly available

Several studies report a significant effect of RYGB surgery on gut microbial composition and metabolic activity with a reduction in fecal short-chain fatty acids (SCFAs) [2,3,4,5], i.e., acetic-, propionic-, and butyric- acid which are the main metabolic outputs of colonic fermentation

By suppressing NF-kB, KPV reduces the expression of pro-inflammatory cytokines including IL-8 and monocyte chemoattractant protein-1 (MCP-1)

Despite the miraculous effect of the drug, its consequences are not fully understood and, therefore, may be dangerous for the unborn child